Daniel MacLachlan - 12 Oct 2022 Form 4 Insider Report for Red Violet, Inc. (RDVT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Oct 2022, 17:31:59 UTC
Prior SEC filing
26 Sep 2022
Next SEC filing
08 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel MacLachlan

Key filing fact

Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 13 Oct 2022.

Key facts

  • This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Oct 2022, 17:31.

Change

  • Previous filing in this sequence was filed on 26 Sep 2022.
  • Current net transaction value: -$78,426.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RDVT transaction

Common Stock

Award

Transaction value
Shares
+10,834
Change %
+3.3%
Price
Shares after
339,537
Date
12 Oct 2022
Ownership
Direct
Footnotes
F1, F2, F3
RDVT transaction

Common Stock

Tax liability

Transaction value
$78,426
Shares
-4,589
Change %
-1.4%
Price
$17.09
Shares after
334,948
Date
12 Oct 2022
Ownership
Direct
Footnotes
F2, F3, F4
RDVT transaction

Common Stock

Award

Transaction value
Shares
+40,000
Change %
+12%
Price
Shares after
374,948
Date
12 Oct 2022
Ownership
Direct
Footnotes
F5
RDVT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
466
Date
12 Oct 2022
Ownership
Held in IRA
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the first vesting of 10,834 restricted stock units (RSUs) of a grant originally approved by the Company's Compensation Committee on September 24, 2021.

Footnote F2

Includes 20,000 RSUs originally granted on November 20, 2020, convertible into common stock of the issuer on a one-for-one basis, which vest in two equal installments on each of November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions.

Footnote F3

Includes 21,666 RSUs originally granted on September 24, 2021, convertible into common stock of the issuer on a one-for-one basis, which vest in two equal installments on each of October 1, 2023 and October 1, 2024, subject to accelerated vesting under certain conditions.

Footnote F4

Represents the disposition to issuer for tax obligations upon the vesting of RSUs.

Footnote F5

On October 12, 2022, the reporting person received a grant of 40,000 RSUs, convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of November 1, 2023, November 1, 2024 and November 1, 2025, subject to accelerated vesting under certain circumstances.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .